| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |